Literature DB >> 10516182

Involvement of ATP-sensitive K(+) channels in spontaneous activity of isolated lymph microvessels in rats.

R Mizuno1, N Ono, T Ohhashi.   

Abstract

Physiological roles of ATP-sensitive K(+) channels for spontaneous activity in isolated rat mesenteric lymph microvessels (maximum diameter approximately 80-150 microm) were investigated. The lymph microvessels were cannulated with glass micropipettes and pressurized at a perfusion pressure of 6 cmH(2)O. Changes in the diameter and frequency of spontaneous contractions in the lymphatics were measured with videomicroscopy. Pinacidil (K(+)-channel opener) inhibited the spontaneous activity. In the presence of glibenclamide (selective ATP-sensitive K(+)-channel blocker; 10(-7) and 10(-6) M) and tetraethylammonium (TEA; nonselective K(+)-channel blocker; 10(-4) and 10(-3) M), the pinacidil-induced inhibition of the spontaneous contractions in lymph microvessels was significantly reversed. Glibenclamide and TEA themselves, however, did not affect the frequency of spontaneous activity in the lymph microvessels. These results suggest that ATP-sensitive K(+) channels are involved in the regulation of spontaneous activity in the smooth muscles of isolated lymph microvessels of rat mesenteries.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516182     DOI: 10.1152/ajpheart.1999.277.4.H1453

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Contraction-initiated NO-dependent lymphatic relaxation: a self-regulatory mechanism in rat thoracic duct.

Authors:  Olga Yu Gasheva; David C Zawieja; Anatoliy A Gashev
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

Review 2.  Lymphatic pumping: mechanics, mechanisms and malfunction.

Authors:  Joshua P Scallan; Scott D Zawieja; Jorge A Castorena-Gonzalez; Michael J Davis
Journal:  J Physiol       Date:  2016-08-02       Impact factor: 5.182

3.  Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct.

Authors:  Anatoliy A Gashev; Michael J Davis; David C Zawieja
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

Review 4.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

Review 5.  KATP channels in lymphatic function.

Authors:  Michael J Davis; Hae Jin Kim; Colin G Nichols
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-04       Impact factor: 5.282

Review 6.  Lymphatic vessels in health and disease.

Authors:  Cristina T Kesler; Shan Liao; Lance L Munn; Timothy P Padera
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-12-03

7.  Kir6.1-dependent KATP channels in lymphatic smooth muscle and vessel dysfunction in mice with Kir6.1 gain-of-function.

Authors:  Michael J Davis; Hae Jin Kim; Scott D Zawieja; Jorge A Castorena-Gonzalez; Peichun Gui; Min Li; Brian T Saunders; Bernd H Zinselmeyer; Gwendalyn J Randolph; Maria S Remedi; Colin G Nichols
Journal:  J Physiol       Date:  2020-05-30       Impact factor: 5.182

8.  Inhibition of myosin light chain phosphorylation decreases rat mesenteric lymphatic contractile activity.

Authors:  Wei Wang; Zhanna Nepiyushchikh; David C Zawieja; Sanjukta Chakraborty; Scott D Zawieja; Anatoliy A Gashev; Michael J Davis; Mariappan Muthuchamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-12       Impact factor: 4.733

Review 9.  Lymphatic Collecting Vessel: New Perspectives on Mechanisms of Contractile Regulation and Potential Lymphatic Contractile Pathways to Target in Obesity and Metabolic Diseases.

Authors:  Yang Lee; Scott D Zawieja; Mariappan Muthuchamy
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

Review 10.  Drug-Related Lymphedema: Mysteries, Mechanisms, and Potential Therapies.

Authors:  Soumiya Pal; Jenat Rahman; Shengyu Mu; Nancy J Rusch; Amanda J Stolarz
Journal:  Front Pharmacol       Date:  2022-03-04       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.